Search This Blog

Thursday, April 9, 2020

Biocept Shares Up on Planned Start of Covid-19 Testing

Shares of Biocept Inc., which provides liquid biopsy tests for cancer patients, rose 12% to 40 cents after hours as the company said it will conduct Covid-19 testing.
Biocept said it has verified a molecular diagnostic test, and plans to begin accepting physician-ordered testing requests for processing beginning April 15.
Biocept’s lab will use Thermo Fisher Scientific Inc.’s TaqPath platform and kit.

https://www.marketscreener.com/BIOCEPT-INC-44644720/news/Biocept-Shares-Up-on-Planned-Start-of-Covid-19-Testing-30394798/

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.